Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,575 USD | -0,32% | +2,94% | -10,51% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 77,48 mln. 72,4 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -33 mln. -30,84 mln. | Nettowinst (verlies) 2025 * | -45 mln. -42,05 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-2,77
x | K/w-verhouding 2025 * |
-2,51
x | Werknemers | 28 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 89,43% |
Recentste transcriptie over Corvus Pharmaceuticals, Inc.
1 dag | +0,32% | ||
1 week | +2,94% | ||
Lopende maand | -11,52% | ||
1 maand | -15,32% | ||
3 maanden | -24,28% | ||
6 maanden | +45,83% | ||
Lopend jaar | -10,51% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 27-01-14 |
Leiv Lea
DFI | Director of Finance/CFO | 70 | 27-01-14 |
James Rosenbaum
CTO | Chief Tech/Sci/R&D Officer | - | 21-07-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 27-01-14 |
Ian Clark
BRD | Director/Board Member | 62 | 03-01-17 |
Terry Gould
BRD | Director/Board Member | 67 | 01-11-14 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
30-04-24 | 1,575 | -0,32% | 9 287 |
29-04-24 | 1,58 | +8,97% | 131 930 |
26-04-24 | 1,45 | -2,03% | 124 494 |
25-04-24 | 1,48 | -1,99% | 66 282 |
24-04-24 | 1,51 | -1,31% | 90 571 |
uitgestelde koers Nasdaq, 30 april 2024 om 16:35 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-10,51% | 77,48 mln. | |
+1,43% | 42,86 mld. | |
+12,34% | 42,74 mld. | |
+44,76% | 41,36 mld. | |
-8,83% | 27,68 mld. | |
+7,33% | 25,15 mld. | |
-23,24% | 18,63 mld. | |
+29,90% | 12,37 mld. | |
-2,87% | 11,92 mld. | |
+7,25% | 11,21 mld. |